pyridoxal has been researched along with Coronary Artery Disease in 1 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulvik, A | 1 |
| Pedersen, ER | 1 |
| Svingen, GF | 1 |
| McCann, A | 1 |
| Midttun, Ø | 1 |
| Nygård, O | 1 |
| Ueland, PM | 1 |
1 other study available for pyridoxal and Coronary Artery Disease
| Article | Year |
|---|---|
Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Hum | 2016 |